FDA Approves Adjuvant Ribociclib Plus an Aromatase Inhibitor for Early-Stage Breast Cancer

back pain; constipation; cough; rash; increased creatinine; and abdominal pain. For adjuvant treatment, the recommended ribociclib dose is 400 mg …
Source: back pain